Latest News

Wideblue client The Impossible Company launches the Wideblue engineered I-1 camera

Wideblue client The Impossible Company have recently launched the Wideblue engineered I-1 camera, the first new camera system in over twenty years for the original Polaroid 600 photo format. The camera was recently launched at the Bloomberg design week in San Francisco and was also featured during NYCxDesign in May at an exclusive launch at MOMA the Museum of Modern Art in new York. The camera is the first in a line of new instant film cameras for the digital age that are currently being developed with Impossible.

Wideblue director Grant King to speak at Bio Dundee Conference

Wideblue director Grant King to speak at Bio Dundee Conference, 24-25th May. As part of a focus on Design, Grant will be speaking to an audience from the Life Sciences community on “Product Design – the idea and the execution; how it all comes together”. In light of Dundee being a UNESCO City of Design and as 2016 is the year of Innovation, Architecture and Design, the 2016 Bio Dundee Conference will focus on the importance of Design in business and product development.

Wideblue demonstrate new capnometer products to Princess Anne

Wideblue are currently working with University of West of Scotland (UWS) Sports Medicine Department, GSS and CENSIS, to evaluate the use of their new Capnometer products in sports medicine. Wideblue and GSS were invited along to the opening of a new building at UWS and got the chance to demonstrate the new products to Princess Anne.

Wideblue customer CRiL start clinical trials at Addenbrookes hospital with new NTC1 product

Cambridge Respiratory Innovations Ltd have received approval to start clinical trials of the new NTC1 product designed and built by Wideblue. Approval was given for the trials by the Cambridge University Hospitals NHS Foundation Trust for “clinical evaluation of the CRIL N-Tidal C data-collector capnometer to collect breathing records in patients with COPD”. Patients with COPD will be recruited for the trial starting in February and given a N Tidal C device to record their capnometry / CO2 breathing records over a few weeks. The trials are due to be completed by the 18th April 2016.

Wideblue complete build of CRiL new NTC1 medical devices for clinical trials

Following the completion of the SOSRC project, Wideblue have commissioned new production quality injection moulding tooling, electronics boards and Infra Red optics to allow the assembly and testing of a new N Tidal C medical device (NTC1) for CRiL (Cambridge Respiratory Innovations Ltd).

This is the first device to be formally tested and is configured as a personal data capture device for the purposes of the COPD clinical trial. In addition to the manufacture and testing of over 30 new medical devices for the trial, Wideblue have also prepared spare units, disposable mouthpieces, diagrams for the various Instruction Manuals, software for the clinical trial users and suitable labelling and packaging.

The devices, which are CE marked by CRiL, have been manufactured under Wideblue’s ISO13485 quality systems.